Search Orphan Drug Designations and Approvals
-
Generic Name: | Pioglitazone hydrochloride |
---|---|
Date Designated: | 07/20/2022 |
Orphan Designation: | Treatment of childhood onset idiopathic nephrotic syndrome (defined as steroid dependent or frequently relapsing NS). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
NephKey Therapeutics, Inc. 15100 Weston Parkway, Suite 101 Cary, North Carolina 27513 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-